Abstract
Study Objective
Human papillomavirus (HPV), the most common sexually transmitted infection in the
United States, can be contracted by young girls shortly after sexual debut. Human
papillomavirus can lead to cervical and anogenital cancers and genital warts. A vaccine
has been developed to protect against precancerous lesions. We examined obstetrician-gynecologists'
practices, opinions, and knowledge regarding this vaccine.
Design
A 37-item questionnaire was sent out by the American College of Obstetricians and
Gynecologists (ACOG) to its fellows and junior fellows between May and November of
2007.
Participants
Surveys went to 3896 fellows and junior fellows of ACOG. Of these surveys, 771 were
Collaborative Ambulatory Research Network (CARN) members who have volunteered to receive
several surveys per year. The remaining 3125 questionnaires were sent to all fellows
and junior fellows in ACOG's District V (Ohio, Kentucky, Indiana, Michigan and Ontario,
Canada). Response rates were 51.0% and 30.7% for CARN and District V, respectively.
Results
Of those who administer vaccines, most offer the HPV vaccine. Most know this vaccine
protects against 4 HPV types. Fewer knew the percentages of cervical cancers and genital
warts prevented. Over 20% knew all 3 answers. Only a minority answered all incorrectly.
Approximately 15% view HPV vaccine as safe in pregnancy. Many agree cost is a reason
for patient refusal and a deterrent from mandating the vaccine.
Conclusion
Obstetrician-gynecologists are knowledgeable of the HPV vaccine and are incorporating
it into practice. Financial concerns may limit widespread immunization.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric and Adolescent GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Department of Health and Human Services: Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices.Morb Mortal Wkly Rep. 2007; : 56
- Natural history of cervicovaginal papillomavirus infection in young women.N Engl J Med. 1998; 338: 423
- The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.J Pediatr. 1998; 132: 277
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol. 1999; 189: 12
American Cancer Society: Cancer Facts and Figures 2007.
- American College of Obstetricians and Gynecologists: Human Papllomavirus. ACOG Practice Bulletin No. 61.Obstet Gynecol. 2005; 105: 905
- HPV vaccine and its recommendations, 2007.J Fam Pract. 2007; 52: S1
- Trends in premarital sex in the United States, 1954-2003.Public Health Rep. 2007; 122: 73
- Early to bed: a study of adaptation among sexually active urban adolescent girls younger than age sixteen.J Am Acad Child Adolesc Psychiatry. 2005; 44: 358
- Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.Am J Epidemiol. 2003; 157: 218
- Risk of female human papillomavirus acquisition associated with first male sex partner.J Infect Dis. 2008; 197: 279
- Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.N Engl J Med. 2007; 356: 1928
- Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection.J Infect Dis. 2007; 196: 1438
Gynecologic Cancer Foundation: State of the state of gynecologic cancers: Fifth annual report to the women of America. 2007. Available at: http://www.thegcf.org/SOS_2007_FINAL081507.pdf
- Overcoming barriers to adherence to HPV vaccination recommendations.Am J Manag Care. 2006; 12: S484
- Understanding and overcoming barriers to human papillomavirus vaccine acceptance: reducing the burden of cervical cancer and HPV-related diseases through vaccination.Curr Opin Obstet Gynecol. 2006; 18: s23
- Predictors of HPV vaccine acceptability: a theory-informed, systematic review.Prev Med. 2007; 45: 107
- Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents.J Low Genit Tract Dis. 2004; 8: 188
- Improving adolescent health: Focus on HPV vaccine acceptance.J Adolesc Health. 2005; 37: S17
- Challenges to accepting a human papillomavirus (HPV) vaccine: a qualitative study of Australian women.Women Health. 2007; 45: 59
- Parental perspectives on vaccinating children against sexually transmitted infections.Soc Sci Med. 2004; 58: 1405
- Attitudes about human papillomavirus vaccine among family physicians.J Pediatr Adolesc Gynecol. 2005; 18: 391
- Pediatrician knowledge and attitudes regarding human papollomavirus disease and its prevention.Vaccine. 2007; 25: 6437
- A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination.Pediatrics. 2006; 118: 2280
- Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs.Vaccine. 2007; 25: 7841
- Initial lessons learned in HPV vaccination.Gynecol Oncol. 2008; 109: S4
American College of Obstetricians and Gynecologists. Human Papillomavirus Vaccination. ACOG Committee Opinion. 2006; publication no. 344.
- Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.Infect Dis Obstet Gynecol. 2004; 12: 127
- A power primer.Psychol Bull. 1992; 112: 155
- HPV vaccination- more answers, more questions.N Engl J Med. 2007; 356: 1991
- Acceptability of human papillomavirus immunization.J Womens Health Gend Based Med. 2000; 9: 47
- Acceptance of human papillomavirus vaccine by gynecologists in an urban setting.J Low Genit Tract Dis. 2008; 12: 118
- Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma.Cancer. 1996; 77: 121
- Concurrent and sequential acquisition of different genital human papillomavirus types.J Infect Dis. 2000; 182: 1097
- Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.J Infect Dis. 2001; 184: 1508
- A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.J Infect Dis. 2001; 183: 8
- Politics, parents, and prophylaxis: mandating HPV vaccination in the United States.New Engl J Med. 2007; 356: 1905
Article info
Footnotes
This study was supported in part by the Centers for Disease Control and Prevention and Grant #R60 MC 05674 from the Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services.
Identification
Copyright
© 2009 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.
